Comparison of elixhauser and charlson methods for predicting oral cancer survival

Medicine (United States)

Volumn 95, Issue 7, 2016, Pages e2861-

  Chang, Heng Jui ^a   Chen, Po Chun ^b   Yang, Ching Chieh ^c   Su, Yu Chieh ^d   Lee, Ching Chih ^e,f,g  

^a MIN SHENG GENERAL HOSPITAL   (Taiwan)

^b PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d DALIN TZU CHI HOSPITAL   (Taiwan)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^g NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; ELIXHAUSER COMORBIDITY INDEX; FEMALE; FOLLOW UP; HUMAN; HYPOTHESIS; ICD-9; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH CANCER; NATIONAL HEALTH INSURANCE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL PREDICTION; ALGORITHM; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; COMPARATIVE STUDY; EPIDEMIOLOGY; MORTALITY; MOUTH NEOPLASMS; PROGNOSIS; TAIWAN;

ADULT; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; TAIWAN;

EID: 84959166634     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002861     Document Type: Article

References (20)

1. Zhang JX, Iwashyna TJ, Christakis NA. The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med Care. 1999;37:1128-1139.
2. Moro-Sibilot D, Aubert A, Diab S, et al. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J. 2005;26:480-486.
3. Kastner C, Armitage J, Kimble A, et al. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting. Prostate Cancer Prostatic Dis. 2006;9:270-274.
4. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
5. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
6. Halfon P, Eggli Y, van MG, et al. Measuring potentially avoidable hospital readmissions. J Clin Epidemiol. 2002;55:573-587.
7. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-1139.
8. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
9. Lieffers JR, Baracos VE, Winget M, et al. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer. 2011;117:1957-1965.
10. Quail JM, Lix LM, Osman BA, et al. Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts. BMC Health Serv Res. 2011;11:146.
11. Health Promotion Administration, Ministry of Health and Welfare. Five years outcome of national program for cancer prevention. http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/TopicBulleti-n.aspx?No5201009170001&parentid5200712250030. Accessed October 10, 2015.
12. Chang TS, Chang CM, Hsu TW, et al. The combined effect of individual and neighborhood socioeconomic status on nasopharyn-geal cancer survival. PLoS ONE. 2013;8:e73889.
13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
14. Hosmer DWLS. Applied Logistic Regression. 2000 2nd ed.
15. Austin SR, Wong YN, Uzzo RG, et al. Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work. Med Care. 2015;53:e65-e72.
16. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004;22:3099-3103.
17. Reid BC, Alberg AJ, Klassen AC, et al. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer. 2001;92:2109-2116.
18. Alho OP, Hannula K, Luokkala A, et al. Differential prognostic impact of comorbidity in head and neck cancer. Head Neck. 2007;29:913-918.
19. Johnston JA, Wagner DP, Timmons S, et al. Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients. Med Care. 2002;40:929-940.
20. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002;40:IV-26-IV-35.